Pharmaceutical Managers in Africa - Building Quality Culture

What if the biggest obstacle to pharmaceutical manufacturing in Africa is not technology? What if it is culture? We can build a modern manufacturing facility, purchase an HPLC, install a new production line, import sophisticated biotechnology equipment, write hundreds of SOPs, even obtain GMP certification. But none of these automatically creates a quality culture. Because the real test of quality happens when: An operator makes a mistake; QC obtains an unexpected result; Production is under pressure to meet a deadline; A critical machine fails during manufacturing; A batch record contains an error; A deviation could delay batch release; Someone discovers a problem just before an inspection. What happens then? 👉 Do people report the problem? Or do they hide it? 👉 Do we investigate the root cause? Or do we simply “retrain the operator”? 👉 Do we stop the process when necessary? Or do we ask QA to “find a solution”? 👉 Do we protect data integrity? Or do we sometimes prioritize a clean-looking record over an accurate one? These are uncomfortable questions. But they are essential questions. Africa is rightly investing in local pharmaceutical production, vaccines and biotechnology. Yet manufacturing capacity without a strong quality culture can create a dangerous illusion of pharmaceutical independence. The future should not be: “How many factories can we build?” It should also be: “How many manufacturers can consistently produce quality-assured medicines to internationally credible standards?” And this applies equally to conventional pharmaceuticals and biotechnology. Resource constraints are real. But a lack of resources should not become a culture of compromise. Because quality culture is not about having unlimited resources, it is about how an organization behaves with the resources it has. I am exploring this subject in my article: ''BUILDING A QUALITY CULTURE IN RESOURCE-LIMITED SETTINGS IN PHARMACEUTICAL MANUFACTURING : CHALLENGES AND OPPORTUNITIES FOR AFRICA'' I would like to hear from professionals involve in pharmaceutical management: What is the single biggest obstacle to building a genuine quality culture in African pharmaceutical manufacturing? Infrastructure? Leadership? Training? Regulatory systems? Financing? Management pressure? Or something deeper? Over the past month, we spent quite some time discussing QC in pharma and honestly, there is still so much more to say about. So, for September, we are moving from: 🔬 “How do we test quality?” to: 🛡️ “How do we build, assure and sustain quality?” Stay tuned for new insights with #NPHARMSTRAININGHUB 🎁